Literature DB >> 2465517

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group.

.   

Abstract

Three hundred seventy eyes with advanced, active, proliferative diabetic retinopathy (PDR) and visual acuity of 10/200 or better were randomly assigned to either early vitrectomy or conventional management. After 4 years of follow-up, the percentage of eyes with a visual acuity of 10/20 or better was 44% in the early vitrectomy group and 28% in the conventional management group. The proportion with very poor visual outcome was similar in the two groups. The advantage of early vitrectomy tended to increase with increasing severity of new vessels. In the group with the least severe new vessels, no advantage of early vitrectomy was apparent.

Entities:  

Mesh:

Year:  1988        PMID: 2465517     DOI: 10.1016/s0161-6420(88)33015-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  38 in total

1.  Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy.

Authors:  Tomoaki Murakami; Akihito Uji; Ken Ogino; Noriyuki Unoki; Shin Yoshitake; Yoko Dodo; Takahiro Horii; Kazuaki Nishijima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2015-05-09       Impact factor: 2.447

2.  Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.

Authors:  B Gupta; R Wong; S Sivaprasad; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

Review 3.  Surgery for postvitrectomy cataract.

Authors:  Diana V Do; Stephen Gichuhi; Satyanarayana S Vedula; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2018-01-10

Review 4.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

5.  The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.

Authors:  Mary Gilbert Lawrence
Journal:  Trans Am Ophthalmol Soc       Date:  2004

6.  Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment.

Authors:  Ellen C La Heij; Sadettin Tecim; Alfons G H Kessels; Albert T A Liem; Wouter J Japing; Fred Hendrikse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-09       Impact factor: 3.117

7.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

8.  Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy.

Authors:  Ashraf M El-Batarny
Journal:  Clin Ophthalmol       Date:  2008-12

9.  Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.

Authors:  Ehud Rechtman; Alon Harris; Hanna J Garzozi; Thomas A Ciulla
Journal:  Clin Ophthalmol       Date:  2007-12

10.  Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy.

Authors:  Siamak Moradian; Hamid Ahmadieh; Mohsen Malihi; Masoud Soheilian; Mohammad Hossein Dehghan; Mohsen Azarmina
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.